This is an Open Access article licensed under the terms of the Creative Commons AttributionNonCommercial-NoDerivs 3.0 License (www.karger.com/OA-license), applicable to the online version of the article only. Distribution for non-commercial purposes only. (RBCs). Previous work has suggested that PKCa directly stimulates the Ca V 2.1 channel, whereas other studies revealed that Ca V 2.1 is insensitive to activation by PKC. The aim of this study was to resolve this discrepancy. Methods: We performed experiments based on a single cell read-out of the intracellular Ca 2+ concentration in terms of Fluo-4 fluorescence intensity and phosphatidylserine exposure to the external membrane leaflet. Measurement modalities included flow cytometry and live cell imaging. Results: Treatment of RBCs with phorbol 12-myristate 13-acetate (PMA) led to two distinct populations of cells with an increase in intracellular Ca 2+ : a weak-responding and a strong-responding population. The EC 50 of PMA for the number of cells with Ca 2+ elevation was 2.7±1.2 µM; for phosphatidylserine exposure to the external membrane surface, it was 2.8±0.5 µM; and for RBC haemolysis, it was 2.9±0.5 µM. Using pharmacological manipulation with the Ca V 2.1 inhibitor w-agatoxin TK and the broad protein kinase C inhibitor Gö6983, we are able to show that there are two independent PMAactivated Ca 2+ entry processes: the first is independent of Ca V 2.1 and directly PKCa-activated, while the second is associated with a likely indirect activation of Ca V 2.1. Further studies using lysophosphatidic acid (LPA) as a stimulation agent have provided additional evidence that PKCa and Ca V 2.1 are not directly interconnected in a signalling chain. Conclusion: Although we provide evidence for a lack of interaction between PKCa and Ca V 2.1 in RBCs, further studies are required to decipher the signalling relationship between LPA, PKCa and Ca V 2.1.
Introduction
An increase in the normally low intracellular Ca 2+ content of human red blood cells (RBCs) [1] activates a number of subsequent cellular mechanisms, leading to changes in cellular properties [2] . This finding is in line with numerous signalling components and cascades identified recently that have provided insight into the cellular responses of human RBCs towards extracellular stimuli [3] [4] [5] [6] [7] .
The Ca
2+
-induced changes include the activation of the phospholipid scramblase [8] and the inhibition of the aminophospholipid translocase [9, 10] , resulting in the exposure of phosphatidylserine (PS) to the external membrane leaflet [9] [10] [11] [12] [13] and the formation of microvesicles [11, 14] . In addition, increased intracellular Ca 2+ content activates the Ca 2+ -activated K + channel (Gardos channel) [15, 16] , resulting in an efflux of KCl and osmotically obliged water, which is accompanied by RBC shrinkage [17, 18] .
RBC stimulation with oleoyl-L-α-lysophosphatidic acid (LPA) is an example of a physiological stimulation leading to an increase in intracellular Ca 2+ [19, 20] . The characterisation of the Ca 2+ entry and the consequent cell behaviour have been described in numerous reports [21] [22] [23] [24] [25] . The question of how exposure to LPA leads to Ca 2+ entry remains far from clear. Current knowledge assumes a signalling cascade in which an unspecified isoform of protein kinase C (PKC) activates a P-type Ca V 2.1 channel [26, 27] . This knowledge is based on pharmacological flow cytometric measurements and on Western blots of Ca V 2.1.
All PKCs are powerful kinases, and several isoforms have been shown to be present in RBCs: PKCα, a member of the conventional PKC subgroup (cPKC); PKCζ, which belongs to the atypical PKC subgroup (aPKC); and PKCι and PKCμ, which are both members of the 4 th subgroup [28] . Members of the novel PKC (nPKC) subgroup could not be found in RBCs [28] . However, evidence was recently provided that such biochemical investigations may be contaminated by polymorphonuclear neutrophil granulocytes [29, 30] and thus overestimate the number of PKC isoforms present in RBCs. However, based on pharmacological experiments that use phorbol esters [22, 27] , there is no doubt about the abundance of PKCα in RBCs.
As mentioned above, Ca V 2.1 was shown to be present in RBCs by Western blotting [27] , and functional studies with the specific inhibitor ω-agatoxin TK support the molecular data [26] . However, investigations of determinants of PKC (two subgroups)-dependent modulation of a family of neuronal Ca 2+ channels revealed that Ca V 2.1 activity is insensitive to activation by these PKC subgroups (including PKCα) [31] . Therefore, we wondered how closely PKCα and Ca V 2.1 signalling are interconnected in RBCs. Of the PKC isoforms mentioned above, only PKCα can be activated by phorbol 12-myristate 13-acetate (PMA) [32] . PMA is a powerful pharmacological tool that activates PKCα in terms of translocation from the cytosol to the plasma membrane even in the absence of Ca 2+ , which is required for binding to the C2 domain of the cPKCs under physiological conditions [33] .
Materials and Methods

Preparation and treatment of RBCs
RBCs from healthy adult donors were used. Blood samples were obtained from the Institute of Sports and Preventive Medicine (Saarland University, Saarbrücken) and from the Institute of Clinical Haematology and Transfusion Medicine (Saarland University Hospital, Homburg). Blood was withdrawn by venipuncture into citrate-coated tubes or with heparin as anticoagulant and used within one day. The blood samples were stored at 4°C until use. RBCs were isolated by centrifugation at 2x10 3 g for 3.5 min, followed by the aspiration of buffy coat and plasma. The remaining RBCs were washed three times in a HEPES-buffered physiological solution (HPS) containing (in mM): 145 NaCl, 7.5 KCl, 10 glucose and 10 HEPES, at pH 7.4. The final centrifugation was performed at 10 4 g for 10 s. For experiments, RBCs were diluted to a haematocrit of 0.1% in HPS containing an additional 2 mM CaCl 2 and incubated with A23187 or PMA. For the LPA experiments, RBCs were diluted in HPS at the same haematocrit; LPA was added first, and within a few seconds, 2 mM CaCl 2 was added. A23187, LPA, and PMA were dissolved in DMSO at 1 mM and stored at -20°C. Incubation was carried out at 37°C, and after their respective incubation times, cells were washed in HPS containing an additional 2 mM CaCl 2 . . Live cell imaging was performed to monitor intracellular Ca 2+ kinetics in individual cells when exposed to PMA or LPA. After being withdrawn and treated as described above, 2x10 7 RBCs in 1 ml slightly modified HPS (containing in mM: 135 NaCl, 5.4 KCl, 10 glucose, 10 HEPES, 1.8 CaCl 2 and 1 MgCl 2 , with pH adjusted to 7.35 with NaOH) were loaded with Fluo-4 AM at a concentration of 5 μM for 1 h at 37°C. Cells were then washed 3 times in HPS as just described. Each 10 6 cells were plated on a coverslip in slightly modified HPS, waiting 15 min for cell sedimentation and dye de-esterification. The video-imaging set-up has been previously described [34] . Images were collected every 5 s for a total period of 15 min. A 505-nm long-pass dichroic mirror separated the emission light from the excitation light (central wavelength 480 nm) and a 535/40-band-pass filter was used as an emission filter. A local perfusion system was utilised to quickly exchange solutions in the field of view and to apply the desired concentrations of substances. For experiments including Gö6983 and/or ω-agatoxin TK, the applied concentration of the antagonists was determined in preliminary experiments to be 1 µM for both substances. At 1 µM, the Ca 2+ response was at a plateau, i.e., a further increase in the concentration did not lead to a further reduction of the Ca 2+ response. Cells were pre-treated with these antagonists for 15-20 min before PMA or LPA stimulation. For the control, the fluorescence intensity of Fluo-4 was measured in slightly modified HPS as defined above (in the presence of 1.8 mM Ca
2+
). Every experiment was performed with at least three different blood samples and repeated at least three times.
Images were processed in ImageJ (Wayne Rasband, National Institute of Health), and traces were performed using Igor Pro software (WaveMetrics Inc., Lake Oswego, OR, USA).
Sources of reagents A23187, LPA, and PMA were purchased from Sigma-Aldrich (St. Louis, MO, USA). Fluo-4, AM and annexin V-FITC were obtained from Invitrogen (Carlsbad, CA, USA). Gö6983 and ω-agatoxin TK were purchased from Tocris (Bristol, UK) and Pepta Nova (Sandhausen, Germany), respectively.
Statistics
Data are presented as the mean values ± S.D. of at least 3 different blood samples. Statistical analysis was performed using Student's t-test when Gaussian distributed. Otherwise, a Mann-Whitney test was performed. The statistical significance of the data is indicated as (***): p ≤ 0.001, (**): p ≤ 0.01, (*): p ≤ 0.05, not significant: p > 0.05.
Results
Recent investigations have explicitly worked out heterogeneously reacting populations of RBCs upon pharmacological stimulation [35] . When stimulating PKCα with PMA, a Ca 2+ entry is known to happen [22, 27] . Therefore, as a first approach, we wanted to probe the distribution of subpopulations of RBC after their stimulation with PMA. Figure 1 shows histograms of RBCs that were stimulated with PMA (Fig. 1A ) in comparison to a straight Ca 2+ entry that was mediated by the Ca 2+ ionophore A23187 [36] (Fig. 1B) and stimulation with the physiologically occurring blood plasma component LPA (Fig. 1C) . PMA stimulation leads to two distinct RBC populations of reacting cells that we term "weak responding RBCs" (WRR) and "strong responding RBCs" (SRR). These two populations comprise all RBCs (there were no non-responding cells) and suggest the involvement of two distinct (Fig. 1B) . LPA stimulation does not resemble PMA stimulation in respect to the distribution of WRR and SRR, but the distribution range in terms of Fluo-4 intensities is very similar when comparing LPA and PMA treatment (Fig. 1C) .
While there are broad characterisations of A23187- [22, 23, 25, 37] and LPA- [11, 20] induced Ca 2+ influx into RBCs available in the literature, reports on the PMA stimulation of RBCs are rather sparse [22, 27, 38] . Therefore, a set of experiments was performed to investigate the effect of various doses of PMA on Ca 2+ content, PS exposure and RBC haemolysis, as shown in Fig. 2 . Figure 2 illustrates the dose response relationship of the parameters mentioned above for PMA concentrations up to 10 µM. Figure 2A depicts the dose-response relationship of the SRR after 30 min PMA treatment (EC 50 = 2.7±1.2 µM). The percentage of cells displaying elevated Fluo-4 intensity increased with PMA dose up to 10 µM PMA, reaching a value of approximately 45% (the increase between 6 and 10 µM was not significant). The dependence of the fluorescence intensities on PMA concentration after 30 min of incubation for the WRR and SRR are shown in Fig. 2B as red triangles and blue circles, respectively. In both cell populations, a slight increase in Fluo-4 intensity with PMA concentration can be observed. With higher PMA concentrations, both the number of cells with elevated Ca 2+ content and the level of this cellular Ca 2+ content slightly increased. To show one of the physiological effector mechanisms of the Ca 2+ increase, Fig. 2C illustrates that increasing PMA concentrations led to significantly larger populations of RBCs with exposed PS. However, with respect to a putative signalling pathway, how the different populations emerge remains an interesting question. The EC 50 of PMA is 2.8±0.5 µM and 2.9±0.8 µM for the effector parameter considered in Fig. 2C (PS exposure) and for haemolysis (Fig. 2D) , respectively. To maintain the balance between induced-Ca 2+ entry (EC 50 of 2.7±1.2 µM) and limited haemolysis, a concentration of 3 µM PMA was selected for further kinetic experiments. 
Cellular Physiology and Biochemistry
Because ω-agatoxin TK was reported to inhibit PMA-induced Ca 2+ influx in RBCs, [27] we aimed to study this process using live cell imaging. Figure 3A depicts these experiments, wherein cells were imaged under control conditions (slightly modified HPS) and under stimulation with 3 µM PMA with and without pre-incubation with 1 µM ω-agatoxin TK. Examining the cell populations, PMA provokes an increase in intracellular Ca
2+
. For the first 3 min, however, there is no change in the intracellular Ca 2+ whether the cells were pre-incubated with ω-agatoxin TK or not, which suggests an initial process that is independent of the Ca V 2.1 channel. After a PMA incubation time of 3 min (4 min of total experiment time), the net Ca 2+ entry of the two groups diverges: the Ca 2+ level remains roughly constant for ω-agatoxin TK pre-incubated cells, while the signal from pure PMA stimulation increases further. The significant differences between the Ca 2+ signal immediately after 2 min of stimulation (3 min of total experiment time) and after 10 min of stimulation (11 min of total experiment time) are depicted in Fig. 3B , strengthening the impression given from the traces observed in Fig. 3A . The average Ca 2+ signals in the presence and absence of ω-agatoxin TK appear very similar in RBCs whether they were stimulated with PMA or LPA (data not shown).
To investigate whether a signalling difference remains between the PMA and LPA stimulations, we performed measurements in which RBCs were probed with LPA and preincubated with or without the broad PKC (cPKC, nPKC, aPKC) inhibitor Gö6983 (grey trace in Fig. 4A ). After initial fluctuations with very little to no difference in the first 4 min after the beginning of the stimulation, there was no significant difference in LPA-induced Ca 2+ influx 5 min after stimulation (6 min of total experiment time) in the presence or absence of Gö6983 (Fig. 4B) . The initial differences may be due to the differing stimulation strength and -ATPase [39, 40] . Later, the Ca 2+ traces diverge, revealing a significant increase in the population without Gö6983 (Fig.  4A ). This result shows that under LPA stimulation, PKCα-mediated Ca 2+ influx does occur, but there are PKCα-independent contributions to the Ca 2+ influx. Because (i) ω-agatoxin TK-blocked Ca 2+ entry is a secondary effect of PKCα activation and (ii) PKCα-mediated Ca 2+ influx is only one contribution to LPA-induced Ca 2+ entry, we wondered what would happen if we blocked both the PKCα activity and the Ca V 2.1 channel. Therefore, we stimulated RBCs with LPA and pre-incubated with Gö6983 and ω-agatoxin TK (green trace in Fig. 4A ). This combined inhibition abolished Ca 2+ entry completely (Fig. 4B) . 
Discussion
The similarity in intensity distribution (WRR and SRR) between PMA stimulation (Fig.  1A) and LPA stimulation (Fig. 1C) leads to the assumption that the two processes induced by the artificial PKCα stimulation resemble processes that occur under LPA stimulation. This assumption holds especially true when considering that the relatively high haemolysis rate after 6 µM PMA treatment may specifically reduce the SRR population. PMA stimulates cPKCs and nPKCs [41] . It has been shown that PKCα is the only isoform among the cPKCs and nPKCs that are found in RBCs (cf. Introduction) [28] . Gö6983 is a broad PKC inhibitor that affects cPKCs, nPKCs and aPKCs but not the 4 th subfamily [42] . Therefore, the pharmacological manipulation of PKC within this paper can be considered an interaction with PKCα.
Although PMA imitates the naturally occurring diacylglycerol (DAG), it is worth mentioning that PMA activates PKCα directly, while the presence/binding of Ca 2+ is compulsory for the physiological activation of PKCα (e.g., by LPA) [33, 43] . In this way, the PMA activation of RBCs, as characterised in Fig. 2 (Fig. 2C) with an EC 50 of 2.8±0.5 µM. This result leads to the conclusion that the Ca 2+ increase in the WRR is sufficient for PS exposition. However, the rate of haemolysis cannot be neglected: at saturation values (> 10 µM PMA), it is approximately 30%. This rate is too high to be acceptable in routine measurements and requires lowering the PMA concentrations towards the EC 50 value; consequently, it was set to 3 µM for the experiments presented in Fig. 3 .
The dose-response curve of haemolysis (Fig. 2D ) was very similar to the PS exposure curve, suggesting a relationship of haemolysis to lipid remodelling in the RBC plasma membrane. Although the EC 50 values of 2.7 µM for the Ca 2+ increase, 2.8 µM for the PS exposure and 2.9 µM for haemolysis fit together, the cell numbers (at EC 50 ) in these processes (30%, 50% and 18%, respectively) point to a more complex interdependence.
Considering the kinetic traces of the Ca 2+ increase in PMA-stimulated RBCs (Fig. 3A) , one can identify two phases. The initial Ca 2+ increase during the first 3 min of stimulation (4 min of total experiment time) is independent of ω-agatoxin TK, i.e., it is not mediated by the Ca V 2.1 channel (cf. Introduction). The following phase shows a continuing increase in the absence of ω-agatoxin TK (almost saturating after 10 min) and no further increase in the presence of ω-agatoxin TK, which suggests an initial PKCα-mediated Ca 2+ influx, which is not through Ca V 2.1 channels, and the activation of Ca V 2.1 can be assumed to be a secondary effect of PKCα activation. In the context of a previous study, this finding is in line with a lack of interaction between PKCα and Ca V 2.1 [31] , thus indicating an indirect effect of PKCα on Ca V 2.1 channel activity.
To probe the similarity between PMA and LPA stimulation of RBCs, we performed LPA stimulation in the presence and absence of Gö6983 (Fig. 4A) . Instead of a total inhibition of the intracellular Ca 2+ increase, we found that there was no difference in intracellular Ca 2+ between the two conditions after 5 min of stimulation (6 min of total experiment time) (Fig.  4B ). This result points to an initial PKCα-independent Ca 2+ entry with a second phase of PKCα-mediated Ca 2+ influx. Conceptually, this is reasonable because PKCα requires Ca 2+ to be activated (see above).
When RBCs are pre-incubated with Gö6983 and ω-agatoxin TK, stimulation with 5 µM LPA does not provoke any increase in intracellular Ca 2+ (green trace in Fig. 4A ). From these 2+ entry. In summary, we were able to show that PKCα activation in RBCs leads to two independent Ca 2+ entry processes. The first is Ca V 2.1 independent, and the second is associated with a likely indirect activation of Ca V 2.1 (Fig. 3) . Further studies using LPA as a stimulation agent provided further evidence that PKCα and Ca V 2.1 are not directly interconnected in a signalling chain (Fig. 4) . This finding is in contrast to the common belief suggested in a previous study [27] . Further investigations are required to decipher the complete signalling cascade from LPA stimulation to Ca 2+ influx in RBCs.
